Mass Continous Suture With PDS Versus Interrupted Suture With Thread on Major Abdominal Incision
NCT ID: NCT03801421
Last Updated: 2021-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2000 participants
INTERVENTIONAL
2019-02-01
2021-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Continuous Versus Interrupted Suturing on Wound Dehiscence and Infection After Abdominal Surgery
NCT07241507
COMPARISON OF CONTINUOUS VERSUS INTERRUPTED-X SUTURING TECHNIQUE FOR CLOSURE OF RECTUS SHEATH IN PATIENTS UNDERGOING EMERGENCY LAPAROTOMY FOR HOLLOW VISCUS PERFORATION
NCT05632146
Interrupted Versus Continuous Subcuticular Skin Suturing in Elective Cesarean Section.
NCT03120806
Three Sutures With Different Absorption Rates for Lower Abdominal Incision
NCT05787171
PDS vs Polyamide for Midline Abdominal Closure
NCT00514566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continous suture group
The surgical incision will be treated by mass continous suture with PDS.
Mass continous suture with PDS
The surgical incision will be treated by mass continous suture with PDS.
Control group
The surgical incision will be treated by interrupted suture with thread.
Interrupted suture with thread
The surgical incision will be treated by interrupted suture with thread.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mass continous suture with PDS
The surgical incision will be treated by mass continous suture with PDS.
Interrupted suture with thread
The surgical incision will be treated by interrupted suture with thread.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the incision is longer than 10 cm
* aged between 18 to 65 years old
Exclusion Criteria
* Patient with diabetes
* Patient with a history of cardiovascular disease, including coronary heart disease and stroke.
* Severe lung diseases such as COPD and asthma
* Patients undergoing emergent or infectious surgery
* Patients with surgical site infection
* No autonomy, inability or unwillingness to participate in follow-up
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhang Xu-Feng
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xu-Feng Zhang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital Xi'an Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XJTU1AFCRC2017SJ-007-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.